Contact: +91-9711224068
International Journal of Applied Research
  • Multidisciplinary Journal
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal

ISSN Print: 2394-7500, ISSN Online: 2394-5869, CODEN: IJARPF

International Journal of Applied Research

Vol. 5, Issue 1, Part D (2019)

Hormone receptor (ER, PR) status in breast carcinoma – correlation with clinicopathological prognostic parameters

Author(s)
Dr. Mahesh C Patil and Dr. Saurabh Shrivastava
Abstract
Background: Breast is one of the most common cause of death in women. Earlier diagnosis and treatment with appropriate therapy based on hormonal status leads to a reduction in mortality rate. Aim of this study is to assess the hormone receptor status in breast carcinomas and to compare them with other clinical and pathological parameters.
Materials and methods: This retrospective study was conducted in Department of Pathology, Vishwabharti Medical College, Kurnool, A.P. for a period of 2 years. A total of 52 cases were studied and IHC were done. ER, PR status of patients were studied and compared with other parameters.
Results: Majority of cases were in postmenopausal women. Clinical stage 2 and histological grade 2 cases were more in number. There was significant correlation between clinical staging and NPI sore and between tumor grade and ER, PR status.
Conclusion: ER, PR status has significant correlation with histological grading but does not have significant correlation with clinical staging. So, irrespective staging and other clinical parameters hormonal studies should be conducted in all cases to reduce mortality and recurrences.
Pages: 249-252  |  374 Views  8 Downloads
How to cite this article:
Dr. Mahesh C Patil, Dr. Saurabh Shrivastava. Hormone receptor (ER, PR) status in breast carcinoma – correlation with clinicopathological prognostic parameters. Int J Appl Res 2019;5(1):249-252.
Call for book chapter
International Journal of Applied Research